China Resources Double-crane Pharmaceutical Co., Ltd. Class ASSE: 600062

Announcement on Completion of Phase III Drug Clinical Trial

· Issued by China Resources Double-crane Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Completion of Phase III Drug Clinical Trial

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment